
Auteur K. J. CULLEN
|
Documents disponibles écrits par cet auteur (3)

V. D. HOPE ; K. J. CULLEN ; S. CROXFORD ; J. V. PARRY ; F. NCUBE | 2014
Dans International Journal of Drug Policy (Vol.25, n°5, September 2014) Article : PériodiqueFactors associated with the sharing of injecting equipment have been widely studied (McKegany, Friedman, & Mesquita, 1998); however, very few studies have looked at the factors associated with the use of cleaned needles/syringes. Those studies t[...]
L. WIESSING ; M. FERRI ; B. GRADY ; M. KANTZANOU ; I. SPERLE ; K. J. CULLEN ; EMCDDA DRID Group ; A. HATZAKIS ; M. PRINS ; P. VICKERMAN ; J. V. LAZARUS ; V. D. HOPE ; C. MATHEI | 2014
Dans PLOS ONE (Vol.9, n°7, July 2014) Article : PériodiqueBackground: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of informati[...]Nouveauté
V. D. HOPE ; J. IVERSEN ; K. J. CULLEN ; J. V. PARRY ; L. MAHER ; F. NUCBE | 2017
Dans International Journal of Drug Policy (Vol.46, August 2017) Article : PériodiqueBackground: While people who inject drugs (PWID) typically use peripheral veins, some inject into their central veins, including the femoral and jugular veins. Injection into the jugular vein can have serious adverse health consequences, includi[...]